Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
2002 Standout
Gastric cancer
2016 Standout
Discontinuation of Antimicrobial Therapy for Febrile, Neutropenic Children with Cancer: A Prospective Study
1997
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
2004
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Efficacy and safety of cefepime: a systematic review and meta-analysis
2007
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
Disseminated Mucormycosis Caused by Absidia corymbifera Leading to Cerebral Vasculitis
2000
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
1998
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
2002 Standout
Once-Daily Oral Levofloxacin Monotherapy versus Piperacillin/Tazobactam Three Times a Day: A Randomized Controlled Multicenter Trial in Patients with Febrile Neutropenia
2004
Management of patients with chronic, refractory idiopathic thrombocytopenic purpura
2000
Cytogenetics in acute leukemia
2003
2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines
2000
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
2004
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
2007
Kinetics of Neutrophils in Mice Exposed to Radiation and/or Granulocyte Colony-Stimulating Factor Treatment
2013
Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients
1999
Diagnosis and management of refractoriness to platelet transfusion
2001
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients
2005
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY
2006
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
2010
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies
2006
Autocrine/paracrine erythropoietin signalling promotes JAK/STAT‐dependent proliferation of human cervical cancer cells
2011
A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma
1996 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Severe Sepsis and Septic Shock
2013 Standout
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
1997
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
2005
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
2002
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
1997
Rhinocerebral zygomycosis following bone marrow transplantation in chronic myelogenous leukaemia. Report of a case and review of the literature
1998
All-trans-Retinoic Acid in Acute Promyelocytic Leukemia
1997
Immune Thrombocytopenic Purpura
2002 Standout
Graft-versus-host disease
2009 Standout
Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids
2011
Intensified Prophylaxis of Febrile Neutropenia with Ofloxacin Plus Rifampin During Severe Short-Duration Neutropenia in Patients with Lymphoma
1999
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines
2010
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Management of the febrile neutropenic cancer patient: lessons from 40 years of study
2005
Hematopoietic Stem-Cell Transplantation
2006 Standout
Allogeneic transplantation of blood stem cells: Coming of age?
2001
Lineage-Specific Hematopoietic Growth Factors
2006
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Emerging causes of iron deficiency anemia refractory to oral iron supplementation
2013
Dengue
2012 Standout
Rhinocerebral zygomycosis treated with liposomal amphotericin B and surgery
1998
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Childhood Leukemias
1995
A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies
2006
An analysis of interleukin-8, interleukin-6 and C-Reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients
1998
Cytokines and hematopoietic stem cell mobilization
2006
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Antifungal Agents. Part I. Amphotericin B Preparations and Flucytosine
1998
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
2002
Empirical antifungal therapy in selected patients with persistent febrile neutropenia
2009
Neutropenic enterocolitis in adults: systematic analysis of evidence quality
2005
A review of autologous hematopoietic cell transplantation
2000 Nobel
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
1995 Standout
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Vancomycin does not benefit persistently febrile neutropenic people with cancer
2004
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)
2007
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell
1997 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Towards a targeted, risk‐based, antifungal strategy in neutropenic patients
2000
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2003
Exploring the full spectrum of macrophage activation
2008 Standout
Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
2005
Mitoxantrone
1996
Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes
2007
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 Standout
Allogeneic Transplantation of CD34+ Selected Hematopoietic Cells—Clinical Problems and Current Challenges
2003
Lack of Efficacy of Prophylactic Platelet Transfusion for Severe Thrombocytopenia in Adults with Acute Uncomplicated Dengue Infection
2009
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Fever of Unknown Origin in Febrile Leukopenia
2007
Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases
1997
Tumor Cell Apoptosis Polarizes Macrophages—Role of Sphingosine-1-Phosphate
2007
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
2006
Zygomycetes in Human Disease
2000 Standout
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand? [see comments]
1994
Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice
1997
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein
2004
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
2003
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Improving antibody affinity by mimicking somatic hypermutation in vitro
1999
Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia
2013
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting
2001
Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine
1999
Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34− fraction
2010
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
1999
Detailed Molecular Delineation of 13q14.3 Loss in B-Cell Chronic Lymphocytic Leukemia
1998
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
2016
Bcl-2 Cooperates with Promyelocytic Leukemia Retinoic Acid Receptor α Chimeric Protein (Pmlrarα) to Block Neutrophil Differentiation and Initiate Acute Leukemia
2001 Nobel
Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
2000
Recent Advances in the Liquid-Phase Syntheses of Inorganic Nanoparticles
2004 Standout
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Iron Supplementation in Nephrology and Oncology: What Do We Have in Common?
2011
Pneumonia in Febrile Neutropenic Patients and in Bone Marrow and Blood Stem-Cell Transplant Recipients: Use of High-Resolution Computed Tomography
1999
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Iron-Deficiency Anemia
2015 Standout
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
2010 StandoutNobel
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Rapid Engraftment Without Significant Graft-Versus-Host Disease After Allogeneic Transplantation of CD34+ Selected Cells From Peripheral Blood
1997
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial
1998 Standout
Locoregional cancer treatment with magnetic drug targeting.
2000
Multiple Myeloma
2011 Standout
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
1995
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
Risks, Costs, and Alternatives to Platelet Transfusions
1999
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Lack of Expression of Thy-1 (CD90) on Acute Myeloid Leukemia Cells With Long-Term Proliferative Ability In Vitro and In Vivo
1997
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Hartmut Link being referenced
September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents
2008
Immunophenotyping is an independent factor for risk stratification in AML
2003
Altered surface marker expression and function of G‐CSF‐induced neutrophils from test subjects and patients under chemotherapy
1994
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
2004
Antimicrobial therapy of unexplained fever in neutropenic patients
2003
Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study
1994
Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies
2003
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients
1996
Interventional antimicrobial therapy in febrile neutropenic patients
1994
High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk
1990
Mitoxantrone, Cytosine Arabinoside, and VP-16 in 36 Patients with Relapsed and Refractory Acute Myeloid Leukemia
1990
Allogeneic transplantation of peripheral blood progenitor cells
1996
Granulocyte growth factors: Achieving a consensus
1995
Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients
1995
Combination of Mitoxantrone and Etoposide in Patients Aged over 60 Years with Untreated Acute Myelogenous Leukemia
1990
European Surveillance of Infections and Risk Factors in Cancer Patients
1999
Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group
1992
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients
1998
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
2007
Recombinant human interferon (IFN) alpha‐2b in chronic myelogenous leukaemia: dose dependency of response and frequency of neutralizing anti‐interferon antibodies
1989
Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL)
1992
Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes
1997
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update
2006
Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients
1996
Management of infections during intensive treatment of hematologic malignancies
1997
Activation-Induced Depletion of Protein Kinase Cα Provokes Desensitization of Monocytes/Macrophages in Sepsis
2005
Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia
1998
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas
1997
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group
1993
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
1997
Transplantation of allogeneic CD34+ blood cells
1996
Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
1996
Successful treatment of Mucor pneumonia in a patient with relapsed lymphoblastic leukemia after bone marrow transplantation.
1993
Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.
1994
A controlled trial of recombinant human granulocyte-macrophage colony- stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma
1992
Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia.
1993